Clinical Relevance of Botulinum Toxin Immunogenicity
Botulinum toxin type A is a 150 kD protein produced by Clostridium botulinum, which exists in a complex with up to six additional proteins. The ability of botulinum toxin to inhibit acetylcholine release at the neuromuscular junction has been exploited for use in medical conditions characterized by...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683397/ |